Shared decision making in Newly Diagnosed Multiple Myeloma | EHA 2026

Shared decision-making is a cornerstone of modern myeloma care, especially for patients facing treatment choices after a new diagnosis. In this interview recorded at EHA 2026, Dr. Fredrik Schjesvold discusses how patients and healthcare providers can work together to select the treatment approach that best aligns with a patient’s disease characteristics, lifestyle, goals, and personal preferences. Learn why there is no one-size-fits-all approach to newly diagnosed multiple myeloma, what factors influence treatment decisions, and how meaningful patient involvement can lead to better outcomes and greater satisfaction with care. #MultipleMyeloma #EHA2026 #SharedDecisionMaking #PatientEmpowerment #MyelomaEducation #NewlyDiagnosedMyeloma #MyelomaTreatment #PatientAdvocacy #HealthTree #MyelomaTeacher If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.